Search for: "In Re Adolphsen" Results 1 - 9 of 9
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Nov 2010, 8:16 am by David Vasella
Es ist wie folgt aufgebaut: Message du Secrétaire Général du TAS / Message from the CAS Secretary General Articles et commentaires / Articles and commentaries Jurisprudence majeure / Leading cases Jurisprudence de la Chambre ad hoc du TAS à Vancouver / Jurisprudence of the CAS ad hoc Division in Vancouver Jugements du Tribunal Fédéral / Judgments of the Federal Tribunal Informations diverses / Miscellaneous Das CAS-Bulletin 1/2010 enthält folgende… [read post]
20 May 2021, 3:20 am by Matthieu Dhenne (Ipsilon)
Jens Adolphsen, Lehrstuhl für Bürgerliches Recht, Nationales und Internationales Zivilverfahrensrecht und Sportrecht€ 199 Patents as an Incentive for Innovation by Rafal Sikorski, Zaneta Zemla-Pacud€ 136 [read post]
11 Jun 2021, 5:01 am by Kluwer Patent blogger
When there was no decision in January, there were many rumours it could come out anytime, but we’re in June now and we’re still waiting. [read post]
10 Jul 2021, 12:18 am by Kluwer Patent blogger
(…) When there was no decision in January, there were many rumours it could come out anytime, but we’re in June now and we’re still waiting. [read post]
§ 271(e)(2). [9] Id. at *14, 17–19. [10] Alvotech at *18–19 (citing In re Rosuvastatin Calcium Patent Litigation, 703 F.3d 511, 528 (Fed. [read post]
9 Jul 2021, 3:11 am by Kluwer Patent blogger
Jens Adolphsen, Lehrstuhl für Bürgerliches Recht, Nationales und Internationales Zivilverfahrensrecht und Sportrecht€ 199 Patents as an Incentive for Innovation by Rafal Sikorski, Zaneta Zemla-Pacud€ 136 [read post]
27 Sep 2021, 3:33 pm by Matthieu Dhenne (Ipsilon)
Jens Adolphsen, Lehrstuhl für Bürgerliches Recht, Nationales und Internationales Zivilverfahrensrecht und Sportrecht€ 199 Patents as an Incentive for Innovation by Rafal Sikorski, Zaneta Zemla-Pacud€ 136 [read post]
18 Jun 2021, 4:34 pm by Rik Lambers (Brinkhof)
The 2010 decision should therefore be considered res judicata in these new proceedings between the parties. [read post]
22 May 2021, 2:07 am by Kluwer Patent blogger
” You’re the editor of the Wolters Kluwer publication ‘Patent Protection for Second Medical Uses’. [read post]